Compumedics Limited (ASX:CMP)

Market Cap	50.94M -6.9%
Revenue (ttm)	61.88M +21.2%
Net Income	214.00K
EPS	0.00
Shares Out	199.76M
PE Ratio	255.00
Forward PE	12.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,100
Open	0.2550
Previous Close	0.2550
Day's Range	0.2550 - 0.2550
52-Week Range	0.2150 - 0.4500
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 175
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 28, 2026

Data Sources Report a data error